Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-randomized, Single Center Clinical Study of Cervical Interbody Fusion Using a Viral-inactivated Allogeneic Graft

NCT04605120 is registered in ClinicalTrials.gov with Biobank as lead sponsor.

NCT NCT04605120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04605120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-randomized, Single Center Clinical Study of Cervical Interbody Fusion Using a Viral-inactivated Allogeneic Graft
Lead sponsor
Biobank
Phase
Not applicable
Overall status
Unknown status
Start date
September 15, 2020
Completion date
September 30, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical disc degeneration, cervical fusion, spinal fusion